Cannabis Stock News- Investing in Cannabis and Hemp Stocks

Tuesday, March 14, 2017

Canadian medical cannabis News: CanniMed Therapeutics Inc. (TSX:CMED) Announces Quarterly Results Release Date

SASKATOON, Saskatchewan - March 14, 2017 (Investorideas.com Newswire) CanniMed Therapeutics Inc. (TSX:CMED) ("CanniMed" or the "Company") announces that it plans to release its financial results for the three months ended January 31, 2017 after markets close on March 16, 2017.

About CanniMed Therapeutics Inc.

The Company is a Canadian-based, international plant biopharmaceutical company and a leader in the Canadian medical cannabis industry, with 15 years of pharmaceutical cannabis cultivation experience, state-of-the-art, GMP-compliant plant production processes and world class research and development platforms with a wide range of pharmaceutical-grade cannabis products. In addition, the Company has an active plant biotechnology research and product development program focused on the production of plant-based materials for pharmaceutical, agricultural and environmental applications.

CanniMed Ltd., through its subsidiaries, was the first producer to be licensed under the Marihuana for Medical Purposes Regulations, the predecessor to the current Access to Cannabis for Medical Purposes Regulations. It was the sole supplier to Health Canada under the former medical marijuana system for 13 years, and has been producing safe and consistent medical marijuana for thousands of Canadian patients, with no incident of product diversion or recalls.

For more information, please visit our websites: www.cannimed.ca (patients) and www.cannimedtherapeutics.com (investors).

Notice Regarding Forward Looking Statements

This news release contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements". Forward-looking statements can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved.

Forward-looking statements are based on assumptions and involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of CanniMed Therapeutics Inc. to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including the risks described in CanniMed Therapeutics Inc.â€™s documents filed with applicable Canadian securities regulatory authorities which may be viewed at sedar.com. The forward-looking statements included in this news release are made as of the date of this news release. CanniMed Therapeutics Inc. does not undertake to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise, unless required by applicable securities legislation.

For more information or to schedule an interview, please contact:

CanniMed Therapeutics Inc.
Dara Willis, 416-836-9272
media@cannimed.com

Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Global Cannabis Investing - features Investor Ideas Cannabis news

Get News Alerts on Marijuana Stocks

More Info:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Viridian Capital Advisors, LLC Added to the 420 Cannabis Investor Ideas of 2017; 420cannabisinvestorideas.com

Viridian Capital Advisors, LLC Added to the 420 Cannabis Investor Ideas of 2017; 420cannabisinvestorideas.com

Investorideas.com – March 14, 2017 – www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks, and www.420cannabisinvestorideas.com announce the most recent addition to the 420 Cannabis Investor Ideas of 2017; Viridian Capital Advisors, LLC.

Read this release in full at http://www.investorideas.com/420cannabisinvestorideas/Companies/Viridian/news/2017/03141LLC.asp

Viridian Capital Advisors

Viridian Capital Advisors, LLC (www.viridianca.com) is a financial and strategic advisory firm dedicated to the cannabis market. We are a data- and market intelligence-driven firm that provides investment banking, M&A, corporate development, and investor relations services to emerging growth companies and qualified investors in the cannabis sector. Our banking practice, through broker-dealer Pickwick Capital Partners, LLC, Member FINRA/SIPC, provides capital and M&A to fund the growth of our clients, while our advisory practice helps to position and build their businesses. Our team’s decades of high level operating and transactional experience on Wall Street in a variety of emerging sectors, allows Viridian to provide comprehensive strategic and financial solutions that assist cannabis enterprises in realizing their full potential.

The 420 Cannabis Investor Ideas of 2017 will feature a maximum of 420 companies to be showcased for a year. Investorideas.com will create a free downloadable PDF of the full directory for investors to use as a reference and due diligence tool.

New Frontier Data, the authority in business intelligence for the cannabis industry, forecasts the legal cannabis market to grow to $24.1 billion by 2025 with a compound annual growth rate of 16%.

Their Cannabis Industry Annual Report: 2017 Legal Marijuana Outlook also found that if all the states which are currently legal continue their projected growth, they could generate $2.3 billion in state tax revenue from retail sales by 2020 and the U.S. Cannabis Market will Create 283,422 Jobs by 2020.

Canadian marijuana sales could top $11-billion within three years, according to recent data from Echelon Wealth.

With all this money at stake its growth opportunity has been compared to the beginnings of the internet. But with all the opportunity comes the risk as well. The directory is meant to one of several tools investors can use as a go- to resource to navigate the sector

Watch 420 Cannabis Investor Ideas Video: https://www.youtube.com/watch?v=e2zFezO580Y

Also listed in the 420 Cannabis Investor Ideas directory:

Aphria Inc. (‘the Company’) (TSX-V: APH or USOTCQB: APHQF) is a Canadian company listed on the TSX Venture Exchange. The Company is located in Leamington, Ontario and is a Health Canada approved licensed producer of high quality 100% greenhouse grown medical cannabis products. Aphria produces and sells their products (currently dried bud and cannabis oil) through 2 primary channels; retail and wholesale. Retail sales are exclusively direct to consumer, a model that is mandated by Health Canada under the ACMPR (‘Access to Cannabis for Medical Purposes Regulations’). Through this model, customers place orders online or by telephone and the product is shipped directly to their address. Aphria’s wholesale business involves selling bulk product to other licensed producers. The company is also committed to supporting cannabis R&D through various means including strategic partnerships and the development of in house capabilities. In short, Aphria is committed to providing pharma-grade medical cannabis and superior patient care, while balancing patient economics and returns to shareholders.www.aphria.com

See more info and listings on www.420cannabisinvestorideas.com

Who can participate and list their company? A publicly traded company on any recognized stock exchange, a private company, a newsletter, equity research provider, technical trading site or any company or service that is participating in the exploding legal marijuana market – tell investors your story. The company must either provide an investor opportunity or resource for researching and learning more about the sector.

Learn more about how to submit your company: http://www.investorideas.com/420cannabisinvestorideas/

About Investorideas.com - News that Inspires Big Ideas

Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.

Sectors we cover in include tech, bitcoin and blockchain, biotech, mining, energy, renewable energy, water stocks, marijuana and hemp stocks, food and beverage (including organic and LOHAS, wine), defense and security including biometrics, Latin America, sports, entertainment, luxury brands and gaming.

The Investorideas.com content portfolio goes beyond the www.investorideas.com site to include 12 blogs on Blogger.com, 7 Artificial Intelligence (AI) websites on the Grid and the Waternewswire.com, all featuring Investorideas.com news and content.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas

Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Follow stocks in your favorite stock sector including marijuana and hemp stocks with Investor Ideas stock directories

http://www.investorideas.com/membership/

Disclaimer: This directory is not a recommendation to buy or sell securities or products or services Investorideas.com charges a fee for placement. The directory is not an endorsement or recommendation but meant to be an investor resource/ due diligence tool.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure: Companies Featured on the 420 Cannabis Investor Ideas have paid a one-time fee of Up to $1000 to be featured on the directory

Contact Investorideas.com

800-665-0411

Monday, March 13, 2017

Cannabis Stock News; APHRIA (TSX VENTURE: $APH) (OTCQB: $APHQF) AFFIRMS ITS COMMITMENT TO PRODUCING SAFE MEDICAL CANNABIS 100% FREE OF CHEMICAL PESTICIDES

Cannabis Stock News; APHRIA (TSX VENTURE: $APH) (OTCQB: $APHQF) AFFIRMS ITS COMMITMENT TO PRODUCING SAFE MEDICAL CANNABIS 100% FREE OF CHEMICAL PESTICIDES

LEAMINGTON, ONTARIO, March 13, 2017 (Investorideas Newswire) In light of recent media coverage, Aphria Inc. ("Aphria" or the "Company") (TSX Venture: APH) (OTCQB: APHQF) issued the following statement with respect to its ongoing commitment to providing pharmaceutical-grade cannabis that is free of chemical pesticides.

Vic Neufeld, Chief Executive Officer of Aphria, said, “Aphria has always held itself to the highest standards when it comes to the cultivation and production of medical cannabis. As part of this, we made a strategic investment in a state-of-the-art greenhouse in Leamington, Ontario, which enables us to produce medical cannabis that meets our exacting standards of quality, consistency, and safety.”

“Aphria is committed to product integrity through every step of the growing process. We make our own fertilizer, which significantly reduces the risk of unwanted chemicals that can be found in ‘pre-mixed’ fertilizers. Additionally, we do not use chemical pesticides in the production of medical cannabis; we only use biological controls in the Leamington greenhouse. To be clear, Aphria has never supported the use of Myclobutanil.”

“Since Aphria was founded, we have enforced a strict Quality Management Program that continuously tests for pesticides, including Myclobutanil. We closely monitor all suppliers to ensure that any products used meet or exceed the minimum standards set to comply with Health Canada's regulations. As we noted in December, we support the use of independent evaluations and testing of medical cannabis as a necessary measure to protect the safety of Canadians.”

“In all, Aphria has adopted pharmaceutical-grade quality assurance and quality control processes, many of which are over and above what is required by Health Canada. We recognize that patients rely on a safe and high quality product to meet their medical needs and it is critically important that all products sold through the ACMPR adhere to the strict guidelines established by Health Canada to ensure that their needs are met.”

“Aphria management has over 35 years of experience in agriculture and 20 years in the pharmaceutical space, we don’t need to rely on chemicals because we know how to grow naturally.”

Read this release in full at http://www.investorideas.com/420cannabisinvestorideas/Companies/APH/news/2017/03131Commitment.asp

About Aphria

Aphria Inc., one of Canada’s lowest cost producers, produces, supplies and sells medical cannabis. Located in Leamington, Ontario, the greenhouse capital of Canada. Aphria is truly powered by sunlight, allowing for the most natural growing conditions available. We are committed to providing pharma-grade medical cannabis, superior patient care while balancing patient economics and returns to shareholders. We are the first public licensed producer to report positive cash flow from operations and the first to report positive earnings in consecutive quarters. For more information, visit www.Aphria.com.

For further information please contact:

Mr. Vic Neufeld

Chief Executive Officer

1-844-427-4742

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “potential”,“believe”, “intend” or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to, statements with respect to internal expectations, estimated margins, timing for completion of final TSX approval, expectations for future growing capacity and costs, the completion of any capital project or expansions, any commentary related to the legalization of marijuana and the timing related thereto, expectations of Health Canada approvals and expectations with respect to future production costs. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the medical marijuana industry in Canada generally, income tax and regulatory matters; the ability of Aphria to implement its business strategies; competition; crop failure; currency and interest rate fluctuations and other risks.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

Neither the TSX Venture Exchange (the “Exchange”) nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

Disclosure : Aphria Inc. ("Aphria" or the "Company") (TSX VENTURE:APH) (OTCQB:APHQF) is a featured company on the 420 Cannabis Investor Ideas of 2017 at www.420cannabisinvestorideas.com

ALGAE DYNAMICS CORP (OTCQB: ADYNF) ANNOUNCES RESEARCH AGREEMENT WITH UNIVERSITY OF WESTERN ONTARIO TO INVESTIGATE THE USE OF CANNABIS DERIVATIVES FOR THE DEVELOPMENT OF NOVEL PHARMACOTHERAPIES FOR MENTAL HEALTH

ALGAE DYNAMICS CORP (OTCQB: ADYNF) ANNOUNCES RESEARCH AGREEMENT WITH UNIVERSITY OF WESTERN ONTARIO TO INVESTIGATE THE USE OF CANNABIS DERIVATIVES FOR THE DEVELOPMENT OF NOVEL PHARMACOTHERAPIES FOR MENTAL HEALTH

TORONTO, CANADA / March 13, 2017 (Investorideas.com Newswire) ALGAE DYNAMICS CORP (OTCQB: ADYNF) (the "Company"), a development stage company focused on the development of unique health products and pharmaceuticals utilizing cannabis and algae oils, today announced a research and product development agreement with Western University to perform research on cannabis oil and its constituents in the context of depression, post-traumatic stress disorder, anxiety and schizophrenia. This is the second of the recently announced research agreements with Canadian universities involving cannabis oil research. This announcement brings Algae Dynamics total university research contributions to $1. 6 million for both programs.

This announcement follows the Company’s previously announced new strategic initiative to explore the extraction of oils from other botanicals, most notably cannabis, and to seek product development and formulation opportunities that combine the benefits of algae and cannabis oils. This research agreement will directly support this initiative and will “focus on translational pharmaceutical research, with a specific focus on identifying how specific phytochemical compounds found in cannabis, including delta-9-tetrahydrocannbinol (THC), cannabidiol (CBD), cannabinoid-derived terpenoids and other potential phytochemical derivatives of cannabis may serve as novel pharmacological treatments for symptoms associated with depression, post-traumatic stress disorder, anxiety and schizophrenia.”

Paul Ramsay, Chairman and President of the Company said, “With this research agreement, we are building upon the previously announced strategic initiative into the use of extracts from cannabis oil, in conjunction with algae oil, to develop unique health products and formulations. In our previous press release, we outlined a three-part approach, the first being Research and Development work with Canadian universities. This is the second of such research agreements relating to the use of botanical extracts including cannabinoids that we expect to employ”.

The investigator leading the research is Dr. Steven Laviolette, a Professor and Neuroscientist in the Schulich School of Medicine & Dentistry at Western University. Dr. Laviolette is a leader in the study of cannabinoids in mental health. Dr. Laviolette’s research team has previously made numerous fundamental discoveries related to how cannabinoids impact and may serve as treatments for mental health disorders including schizophrenia, depression, post-traumatic stress disorder and anxiety. Dr. Laviolette’s primary research focus is in characterizing how specific phytochemical derivatives of cannabis may interact with specific brain pathways and molecular mechanisms whereby they may improve symptoms associated with various mental health disorders. Research from Dr. Laviolette’s team has been published in the top neuroscience and psychiatry journals in the world. His full profile may be seen on the Western University, website www.uwo.ca:

http://www.schulich.uwo.ca/anatomy/people/bios/faculty/laviolette_steve.html

The Company’s contribution to the four-year Sponsored Research Agreement, which commences April 1, 2017 and terminates March 30, 2021, is C$250,000 per year. The Company believes, from past experience, that it will be able to leverage the research expenditures with matching scientific grants pursuant to programs of various branches of government. The Company will be responsible for the filing of patents relating to this research and will own such patents if and when issued. The Company has agreed to make payments to the University upon filing of each patent, when each patent is issued, after first commercial sale and when gross sales reach C$1,000,000. There are no ongoing royalty payments, relating to the use of the patents. The workplan may be extended and modified to achieve best outcomes which may include 1) delegating specific research areas of research work that require additional technologies to appropriate providers; and 2) engaging research collaborators to extend the research into additional areas of benefit to the Company.

The Company’s core product development strategy has been the production of high volume specific algae species and extraction of Essential Fatty Acids (EFAs) which is the foundation of the endocannabinoid system (ECS). The ECS is a group of endogenous cannabinoid receptors located in the mammalian brain and throughout the central and peripheral nervous systems, consisting of neuromodulatory lipids and their receptors. The extracted algae Omega 3 oil with high concentrations of DHA is used as a health supplement product. In light of the potential synergies, the Company has developed its strategy which is aimed at developing new products and formulations that combine the health benefits of algae and cannabis oils.

As reported earlier, the Company is continuing to seek opportunities to partner with or take ownership in existing Access to Cannabis for Medical Purposes Regulations (ACMPR) licensed producers to allow for access to the marketplace.

Read this release in full at http://www.investorideas.com/CO/ADYNF/news/2017/03131ResearchAgreement.asp

About Algae Dynamics Corp

ADC is currently engaged in the development of unique health products and pharmaceuticals that utilize hemp, cannabis and algae oils. This is an extension of our plan to commercialize our proprietary BioSilo(R) algae cultivation system for the high volume, low cost production of pure contaminant-free algae biomass which is high in Omega-3 fatty acids. We have engaged two Canadian universities to provide research into the use of extracts from cannabis oil, which we plan to use to develop products that combine the significant health benefits of Omega-3s derived from algae oil and extracts from cannabis oil. Our research is focusing on the use of cannabis oil in the context of cancer, and the use of cannabis derivatives for the development of novel pharmacotherapies for mental health.

NOTE REGARDING FORWARD-LOOKING STATEMENTS

This news release contains "forward-looking statements" as that term is defined in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, use of proceeds and the development, costs and results of current or future actions and opportunities in the sector. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies, our ability to raise the additional funding we will need to continue to pursue our exploration and development program, and our ability to retain important members of our management team and attract other qualified personnel. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

FOR MORE INFORMATION, PLEASE CONTACT:

Paul Ramsay
Phone: 289-997-6740
Email: ramsay@algaedynamics.com

www.algaedynamics.com

Disclosure:ALGAE DYNAMICS CORP (OTCQB: ADYNF) is a featured company on the 420 Cannabis Investor Ideas of 2017 at www.420cannabisinvestorideas.com

Friday, March 10, 2017

This Week’s New Cannabis / Hemp Stocks Added; $AGH.CA, $GRSO, $LIB.CA, $POTN

This Week’s New Cannabis / Hemp Stocks Added; $AGH.CA, $GRSO, $LIB.CA, $POTN

Also Added to Investor Ideas Marijuana / Hemp List: $VGPR, $VPOR, $VMNT, $VPRB, $HERB

Point Roberts, WA, Delta BC – March 10, 2017 – Investorideas.com, a global news source and investor resource covering actively traded sectors announces this week’s additions to its cannabis /hemp stock directory for investors following the sector.

Investorideas.com tracks companies in high profile trading sectors and makes ongoing additions to its stock directories for each sector. Listing for the stock directories include companies on the TSX, OTC, NYSE, NASDAQ and global stock exchanges.

This week’s additions include a company with a hemp crop in China, a healthcare tech company and a company involved in developing hemp extracts and CBD oils. Other companies include those with vape related products.

Also new is Vemanti Group, Inc. (OTC:VMNT), a tech company that intends to provide a technology platform for the legal cannabis industry to transact safely, securely, and remain fully-compliant via a cash-free mobile payments service.

In conjunction with these additions, Investorideas.com and its cannabis related sites recently launched a new campaign to find and create the top 420 Cannabis Investor Ideas of 2017. www.420cannabisinvestorideas.com

The Top 420 Cannabis Investor Ideas of 2017 - Investorideas.com, 420cannabisinvestorideas.com and Globalcannabisinvesting.com Launch Campaign for Finding Investing Ideas in Sector

Read the full news release for more details at http://www.investorideas.com/news/2017/marijuana/02212Top420.asp

Investor Ideas has also expanded its comprehensive coverage of the space with the recent addition of the new blog, Cannabis Stock News, featuring the latest cannabis and hemp stock news from www.investorideas.com at http://cannabisstocknews.blogspot.com.

Read this release in full at http://www.investorideas.com/news/2017/marijuana/03101Stocks.asp

New Marijuana Companies Added:

Alternate Health Corp. (CSE:AHG; OTC:ATEHF) is a diversified healthcare company that uses its expertise in technology to revolutionize patient care and service delivery in both traditional and complementary medical fields. With investments in research, education and cutting edge technology, Alternate Health is a leader in software applications and processing systems for the medical industry using proprietary technology platforms. Through its subsidiaries, Alternate Health offers services ranging from medical practice and controlled substance management software to blood analysis and toxicology labs, to clinical research and continuing education programs. Alternate Health’s goal is to continue to lead the medical industry with data-driven results in patient care and product development.

Grow Solutions Holdings,Inc. (OTC:GRSO) is focused on the development/distribution of high-demand products and services for cultivation, processing, and consumption of cannabis.

Liberty Leaf Holdings (CSE:LIB) is a new Canadian-based, public company whose focus is to build and support a diversified portfolio of cannabis sector businesses, including cultivation, value added CBD/THC products, biotech research, and supply chain products within this dynamic and fast growing sector.

PotNetwork Holding Inc. (OTC:POTN) is a publicly traded company with two wholly owned subsidiaries, Sunrise Auto Mall Inc. and First Capital Venture Co. and its wholly owned subsidiary Diamond CBD. First Capital Venture Co. through its wholly owned subsidiary, Diamond CBD, is a progressive organization focused on the advanced research and development of the industry's finest premium hemp extracts and making them available to the global marketplace. The Company's notable team, consisting of hemp industry pioneers and natural product experts, chemists, and scientists, is dedicated to producing the finest and purest CBD oil.

NewGen Concepts, Inc. (OTC:VPOR) acquires and develops commercially viable intellectual property. Formerly Vapor Group, it focused on the manufacture and marketing of vaporizers, e-cigarettes and e-liquids. Through its subsidiary, Smart Wheels, Inc., it markets "Whizboard" scooters. The Company's subsidiary, Total Vapor, Inc., is the worldwide distributor of the revolutionary, hand-held automatic Easy Grinder™, designed for the MJ market.

Vega Biofuels, Inc. (OTC:VGPR) is a cutting-edge energy company that manufactures and markets a renewable energy product called Bio-Coal and a soil enhancement called Biochar, both made from timber waste using unique technology called torrefaction. Torrefaction is the treatment of biomass at high temperatures under low oxygen conditions.

Vemanti Group, Inc. (OTC:VMNT) is a diversified holding corporation that's looking to be active in high-growth and technology-driven markets. The company plans to grow by adding value-added and fundamentally-sound businesses to their portfolio The Company intends to provide a technology platform empowering the legal cannabis industry to transact safely, securely, and remain fully-compliant via a cash-free mobile payments service. The Company recently signed a Memorandum of Understanding (MOU) with a well-established payment processor whose services mainly target clients with unique and special needs to co-develop a sustainable electronic payment service for the cannabis industry. It is also in active talks to partner with potential acquiring and merchant banks in a closed-loop banking program designed to help both financial institutions and dispensary owners create a legitimate business banking relationship that is fully compliant with current and future governmental regulations. The Company intends to first roll this service out in California which recently, with the passing of Proposition 64, has become potentially the single biggest recreational cannabis market in the world.

VPR Brands, LP (OTC:VPRB) is a technology company, whose assets include issued U.S. and Chinese patents for atomization related products including technology for medical marijuana vaporizers and electronic cigarette products and components. The company is also engaged in product development for the vapor or vaping market, including e-liquids, vaporizers and electronic cigarettes (also known as e-cigarettes) which are devices which deliver nicotine and or cannabis through atomization or vaping, and without smoke and other chemical constituents typically found in traditional products.

YaSheng Group (OTC:HERB) is a U.S. company and conducts business operations in China in three major segments: agriculture, livestocks, and biotechnology. The company specializes in developing, processing, marketing, and distributing a variety of food products processed primarily from premium specialty agriculture products grown in North West China in 6 agricultural segments: field crops, vegetables, fruits, special crops, seeds and poultry. We have been producing our premium specialty agriculture products over 20 years and some of our entities were founded over 40 years ago, to become a top agriculture company in China. Our major customers include world class conglomerates such as Tsingtao Beer, KFC and McDonalds. Priorities from Yasheng's inception have been to acquire a vast amount of land long-term for large scale industrial agro bases, with the necessary natural resources to provide a long-term infrastructure for people to work these basic ingredients to create high-end agriculture products. Products include: Langfang poplars, peaches, and saplings, durum wheat (flower), cotton, cotton processing, hemp, corn seeds and processing, dried fruit packages, garlic extract gels, feed materials, flowers, fruits, potato, hops extracts, pellet and compressed hops, Chinese TCM herbs, seeds, and many other agro products.

Investorideas.com global stock directories are part of the membership program on the site, accessed either by login and password or available in PDF format. The directories include stocks trading on the TSX, OTC, NASDAQ, NYSE and other recognized global stock exchanges, giving retail investors a wide variety of stocks to review. http://www.investorideas.com/membership/

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Ideas

Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.

Sectors we cover include tech, bitcoin and blockchain, biotech, mining, energy, renewable energy, water stocks, marijuana and hemp stocks, food and beverage (including organic and LOHAS, wine), defense and security (including biometrics), Latin America, sports, entertainment, luxury brands and gaming.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas

Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

JOIN Investor Ideas

http://www.investorideas.com/membership/

Services for Publicly traded companies: http://www.investorideas.com/Investors/Services.asp

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution,social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Contact Investorideas.com

800-665-0411

Marijuana / Hemp Stocks

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Global Cannabis Investing - features Investor Ideas Cannabis news

Get News Alerts on Marijuana Stocks

about Investorideas.com

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .